JPS6317850A
(ja)
|
1986-07-11 |
1988-01-25 |
Fuji Photo Film Co Ltd |
3−フエノキシカテコ−ル類の製造方法
|
DK611489A
(da)
|
1988-12-08 |
1990-06-09 |
Duphar Int Res |
Anxiolytisk aktive piperazinderivater og farmaceutiske praeparater med indhold af saadanne forbindelser
|
JPH02255674A
(ja)
|
1989-03-27 |
1990-10-16 |
Fuji Photo Film Co Ltd |
4―アリールオキシ―1,3―ベンゾジオキソール類およびその製造方法
|
JPH02255673A
(ja)
|
1989-03-27 |
1990-10-16 |
Fuji Photo Film Co Ltd |
4―アリールオキシー1,3―ベンゾジオキソール類およびその製造方法
|
JPH02269352A
(ja)
|
1989-04-10 |
1990-11-02 |
Fuji Photo Film Co Ltd |
感光材料
|
JP2537682B2
(ja)
|
1989-04-21 |
1996-09-25 |
富士写真フイルム株式会社 |
3―アリ―ルオキシカテコ―ル類の製造方法
|
US5296497A
(en)
|
1989-05-16 |
1994-03-22 |
Duphar International Research B.V. |
3,4-dehydropiperidine derivatives having psychotropic activity
|
JPH03130280A
(ja)
|
1989-10-17 |
1991-06-04 |
Fuji Photo Film Co Ltd |
4―アリールオキシ―1,3―ベンゾジオキソール類の製造方法
|
JP2816492B2
(ja)
|
1990-05-23 |
1998-10-27 |
コニカ株式会社 |
ハロゲン化銀写真感光材料
|
JPH0446175A
(ja)
|
1990-06-14 |
1992-02-17 |
Fuji Photo Film Co Ltd |
5―ヒドロキシ―3,4―メチレンジオキシ安息香酸誘導体の製造法
|
JPH0641038A
(ja)
|
1992-07-17 |
1994-02-15 |
Mitsubishi Kasei Corp |
カルボン酸誘導体
|
DE4326151A1
(de)
|
1993-08-04 |
1995-02-09 |
Hoechst Ag |
Aromatische Verbindungen und ihre Verwendung in flüssigkristallinen Mischungen
|
US5629200A
(en)
|
1993-11-18 |
1997-05-13 |
Daicel Chemical Industries, Ltd. |
Production of optically active 2-amino-1-phenylethanol derivatives by asymetrical assimilation
|
US5514505A
(en)
|
1995-05-15 |
1996-05-07 |
Xerox Corporation |
Method for obtaining improved image contrast in migration imaging members
|
NZ331549A
(en)
|
1996-01-29 |
2000-09-29 |
Univ California |
Compounds useful in treating sexual dysfunction
|
US5968929A
(en)
|
1996-10-30 |
1999-10-19 |
Schering Corporation |
Piperazino derivatives as neurokinin antagonists
|
JPH10287654A
(ja)
|
1997-04-11 |
1998-10-27 |
Nissan Chem Ind Ltd |
ピラゾロン誘導体及び除草剤
|
BR9814106A
(pt)
|
1997-10-27 |
2000-10-03 |
Cortex Pharma Inc |
Processo para tratar da esquizofrenia em um indivìduo, e, conjunto
|
KR100705142B1
(ko)
|
1998-09-29 |
2007-04-06 |
와이어쓰 홀딩스 코포레이션 |
단백질 티로신 키나제 억제제로서 치환 3-시아노퀴놀린
|
EP1384713B1
(fr)
*
|
1998-12-23 |
2008-10-15 |
SmithKline Beecham Corporation |
Derives de 4-amino-azepan-3-one comme inhibiteurs de protease
|
US7977333B2
(en)
|
2000-04-20 |
2011-07-12 |
Bayer Healthcare Llc |
Substituted pyridines and pyridazines with angiogenesis inhibiting activity
|
US6451814B1
(en)
|
2000-07-17 |
2002-09-17 |
Wyeth |
Heterocyclic β-3 adrenergic receptor agonists
|
EE05387B1
(et)
|
2000-08-21 |
2011-02-15 |
Astrazenecaab |
KinasoliiniÁderivaadid,ÁnendeÁvalmistamismeetodÁjaÁkasutamine
|
AU2001281246A1
(en)
|
2000-08-23 |
2002-03-04 |
The Procter And Gamble Company |
Benzimidazoles and analogues and their use as neutrophil inhibitors
|
AU2001286702B2
(en)
|
2000-08-24 |
2008-03-13 |
University Of Pittsburgh |
Thioflavin derivatives and their use in diagnosis and theraphy of alzheimer's disease
|
AUPR255401A0
(en)
|
2001-01-16 |
2001-02-08 |
Novogen Research Pty Ltd |
Regulation of lipids and/or bone density and compositions therefor
|
EP1368024A4
(fr)
|
2001-03-16 |
2009-03-18 |
Novogen Res Pty Ltd |
Traitement de la restenose
|
JP4172541B2
(ja)
|
2001-04-09 |
2008-10-29 |
ノバルティス バクシンズ アンド ダイアグノスティックス, インコーポレーテッド |
グアニジノ化合物
|
EP1381599B1
(fr)
|
2001-04-19 |
2008-09-24 |
Astrazeneca AB |
Derives quinazoline
|
DE10148618B4
(de)
|
2001-09-25 |
2007-05-03 |
Schering Ag |
Substituierte N-(1,4,5,6-Tetrahydro-cyclopentapyrazol-3-yl)-Derivate, deren Herstellung und Verwendung als Arzneimittel
|
DE10148617A1
(de)
|
2001-09-25 |
2003-04-24 |
Schering Ag |
Substituierte N-(1,4,5,6-Tetrahydro-cyclopentapyrazol-3-yl)-Derivate, deren Herstellung und Verwendung als Arzneimittel
|
AUPR846401A0
(en)
|
2001-10-25 |
2001-11-15 |
Novogen Research Pty Ltd |
6-Hydroxy isoflavones, derivatives and medicaments involving same
|
EP1503986B1
(fr)
|
2001-12-21 |
2015-09-30 |
Cytokinetics, Inc. |
Compositions et methodes permettant de traiter l'insuffisance cardiaque
|
AU2003219652A1
(en)
|
2002-01-08 |
2003-07-30 |
Eisai Co. Ltd. |
Eponemycin and epoxomicin analogs and uses thereof
|
WO2003062392A2
(fr)
|
2002-01-18 |
2003-07-31 |
Ceretek Llc |
Procedes pour traiter des pathologies associees a un recepteur d'edg
|
US7196108B2
(en)
|
2002-03-08 |
2007-03-27 |
Incyte San Diego Inc. |
Bicyclic heterocycles for the treatment of diabetes and other diseases
|
WO2003086386A1
(fr)
|
2002-04-09 |
2003-10-23 |
Novogen Research Pty Ltd |
Procedes therapeutiques et compositions associees contenant des structures isoflav-3-ene et isoflavan
|
DE10219294A1
(de)
|
2002-04-25 |
2003-11-13 |
Schering Ag |
Substituierte N-(1,4,5,6-Tetrahydro-cyclopentapyrazol-3-yl)-Derivate, deren Herstellung und Verwendung als Arzneimittel
|
CN100486973C
(zh)
|
2002-07-29 |
2009-05-13 |
霍夫曼-拉罗奇有限公司 |
新苯并间二氧杂环戊烯类
|
AU2002951271A0
(en)
|
2002-09-06 |
2002-09-19 |
Novogen Research Pty Ltd |
Repair of dna mutagenic damage
|
JP2006508058A
(ja)
|
2002-09-23 |
2006-03-09 |
ノボジェン・リサーチ・プロプライエタリー・リミテッド |
皮膚光老化および光線性損傷の治療
|
JP4908210B2
(ja)
|
2003-07-28 |
2012-04-04 |
メルク セローノ ソシエテ アノニム |
Pi3キナーゼ阻害剤として使用するための2−イミノ−4−(チオ)オキソ−5−ポリシクロビニルアゾリン類
|
CA2539117A1
(fr)
|
2003-09-24 |
2005-04-07 |
Methylgene Inc. |
Inhibiteurs d'histone deacetylase
|
CA2546643A1
(fr)
|
2003-11-18 |
2005-06-02 |
Novogen Research Pty Ltd |
Promedicaments a base d'isoflavonoides, compositions de ces promedicaments et procedes therapeutiques les impliquant
|
EP1686981A4
(fr)
|
2003-11-19 |
2011-02-23 |
Novogen Res Pty Ltd |
Compositions et procedes de radiotherapie et de chimiotherapie combinatoires
|
GT200500008A
(es)
|
2004-01-16 |
2005-08-16 |
|
Intermediarios de quinolina como inhibidores de receptores de tirosina quinasas y la sintesis de los mismos
|
AR048528A1
(es)
|
2004-04-07 |
2006-05-03 |
Millennium Pharm Inc |
Compuestos derivados de quinolina como antagonistas del receptor de pgd2 para el tratamiento de enfermedades inflamatorias y composiciones farmacéuticas que los contienen.
|
US20050245529A1
(en)
|
2004-04-14 |
2005-11-03 |
Boehringer Ingelheim International Gmbh |
Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds
|
US7846959B2
(en)
|
2004-05-07 |
2010-12-07 |
Exelixis, Inc. |
Raf modulators and methods of use
|
MXPA06013250A
(es)
|
2004-05-14 |
2007-02-28 |
Abbott Lab |
Inhibidores de quinasa como agentes terapeuticos.
|
ITMI20041347A1
(it)
|
2004-07-05 |
2004-10-05 |
Italfarmaco Spa |
Derivati di alfa-amminoacidi ad attivita'antiinfiammatoria
|
SE0401971D0
(sv)
|
2004-08-02 |
2004-08-02 |
Astrazeneca Ab |
Piperidne derivatives
|
MX2007004302A
(es)
|
2004-10-12 |
2007-06-07 |
Applied Research Systems |
Inhibidores de pi3 cinasa gamma para el tratamiento de anemia.
|
SE0402635D0
(sv)
|
2004-10-29 |
2004-10-29 |
Astrazeneca Ab |
Chemical compounds
|
JP2006145294A
(ja)
|
2004-11-17 |
2006-06-08 |
Univ Nagoya |
蛍光標識を行うラベル化試薬、リガンドを表面にもつ基材の製造方法及びラベル化試薬を用いた測定方法
|
US7524870B2
(en)
|
2004-12-03 |
2009-04-28 |
Hoffmann-La Roche Inc. |
Biaryloxymethylarenecarboxylic acids as glycogen synthase activators
|
SI1859793T1
(sl)
|
2005-02-28 |
2011-08-31 |
Eisai R&D Man Co Ltd |
Nova kombinirana uporaba sulfonamidne spojine za zdravljenje raka
|
US20060223846A1
(en)
|
2005-03-08 |
2006-10-05 |
Dyatkin Alexey B |
Aza-bridged-bicyclic amino acid derivatives as alpha4 integrin antagonists
|
EP1893605A2
(fr)
|
2005-03-31 |
2008-03-05 |
AstraZeneca AB |
Derives de s-aminopyrimidine inhibiteurs de tie2
|
KR20070120182A
(ko)
|
2005-04-08 |
2007-12-21 |
바이엘 파마슈티칼스 코포레이션 |
피리미딘 유도체 및 암의 치료에서의 이의 용도
|
ES2614080T3
(es)
|
2005-05-17 |
2017-05-29 |
Sarcode Bioscience Inc. |
Composiciones y métodos para el tratamiento de trastornos oculares
|
RU2007139544A
(ru)
|
2005-05-25 |
2009-06-27 |
Вайет (Us) |
Способ получения 3-цианохинолинов и промежуточные соединения, полученные согласно данному способу
|
WO2006129609A1
(fr)
|
2005-05-30 |
2006-12-07 |
Shionogi & Co., Ltd. |
Derive 2-naphtylimino-5,5-disubstitue-1,3-thiazine
|
AU2006252768A1
(en)
|
2005-06-02 |
2006-12-07 |
Bayer Cropscience Ag |
Phenylalkyl substituted heteroaryl devivatives
|
WO2006138418A2
(fr)
|
2005-06-14 |
2006-12-28 |
President And Fellows Of Harvard College |
Amelioration de la performance cognitive avec des activateurs de sirtuine
|
EP1904069B1
(fr)
|
2005-07-15 |
2018-06-13 |
Albany Molecular Research, Inc. |
Tetrahydrobenzazepines substituees par aryle et heteroaryle, et leur utilisation pour bloquer la reabsorption de la noradrenaline, de la dopamine, et de la serotonine
|
CA2616224A1
(fr)
|
2005-07-21 |
2007-02-01 |
Paratek Pharmaceuticals, Inc. |
Tetracyclines 10-substituees et leurs procedes d'utilisation
|
WO2007019083A1
(fr)
|
2005-08-04 |
2007-02-15 |
Janssen Pharmaceutica N.V. |
Composes de pyrimidine utiles comme modulateurs des recepteurs de la serotonine
|
US7737166B2
(en)
|
2005-08-17 |
2010-06-15 |
Daiichi Sankyo Company, Limited |
Antifungal bicyclic hetero ring compounds
|
WO2007081630A2
(fr)
|
2005-12-21 |
2007-07-19 |
Janssen Pharmaceutica, N.V. |
Inhibiteurs substitues de la pyrimidinyl kinase
|
CN101007798B
(zh)
|
2006-01-24 |
2011-01-26 |
中国人民解放军军事医学科学院毒物药物研究所 |
苯并间二氧杂环戊烯衍生物及其制备方法和医药用途
|
EA015198B1
(ru)
|
2006-03-23 |
2011-06-30 |
Биота Юроп Лимитед |
Антибактериальные агенты
|
KR101458194B1
(ko)
|
2006-05-30 |
2014-11-03 |
뉴로서치 에이/에스 |
신규한 1,4―디아자―비사이클로[3.2.2]노닐 옥사디아졸릴 유도체 및 이의 의학적 용도
|
US20100035877A1
(en)
|
2006-06-26 |
2010-02-11 |
Katz David M |
Methods and compositions for treating pathologies associated with bdnf signaling
|
WO2008029168A2
(fr)
|
2006-09-08 |
2008-03-13 |
Summit Corporation Plc |
Traitement de la dystrophie musculaire de duchenne
|
CA2668008A1
(fr)
|
2006-10-30 |
2008-05-08 |
Novogen Research Pty Ltd |
Prevention et inversion de la neuropathie peripherique induite par une chimiotherapie
|
RU2333211C1
(ru)
|
2006-11-01 |
2008-09-10 |
Институт физиологически активных веществ Российской Академии наук |
N,n`-замещенные 3, 7-диазабицикло[3.3.1]нонаны, обладающие фармакологической активностью, фармацевтические композиции на их основе и способ их применения
|
MX2009011923A
(es)
|
2007-05-10 |
2009-11-18 |
Amr Technology Inc |
Tetrahidrobenzo-1,4-diazepinas aril- y heteroaril-sustituidas y uso de las mismas para bloquear reabsorcion de norepinefrina, dopamina y serotonina.
|
BRPI0704074B8
(pt)
|
2007-08-29 |
2021-05-25 |
Univ Estadual Paulista Julio De Mesquita Filho Unesp |
derivados piperidínicos da (-)-cassina e (-)-spectalina, composições farmacêuticas contendo os mesmos e processos para sua preparação
|
ES2830024T3
(es)
|
2007-10-19 |
2021-06-02 |
Novartis Ag |
Composiciones y métodos para el tratamiento del edema macular
|
KR20100132550A
(ko)
|
2008-04-16 |
2010-12-17 |
포톨라 파마슈티컬스, 인코포레이티드 |
syk 또는 JAK 키나제 억제제로서의 2,6-디아미노-피리미딘-5-일-카르복스아미드
|
WO2010008761A1
(fr)
|
2008-06-23 |
2010-01-21 |
Janssen Pharmaceutica Nv |
Antagonistes pipéridyl-acrylamide de ccr2
|
WO2010019772A2
(fr)
|
2008-08-14 |
2010-02-18 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Oxadiazole-2-oxydes en tant qu'agents antischistosomiaux
|
JP2010254629A
(ja)
|
2009-04-27 |
2010-11-11 |
Bayer Cropscience Ag |
光学活性アゾリン誘導体
|
US9206173B2
(en)
|
2009-05-28 |
2015-12-08 |
Otsuka Pharmaceutical Co., Ltd. |
Heterocyclic compounds for the treatment of stress-related conditions
|
AU2010270153A1
(en)
|
2009-07-10 |
2012-02-02 |
Vivalis |
Substituted pyrrolidinone as inhibitors of hepatitis C NS5B polymerase, the pharmaceutical composition thereof and their therapeutic use
|
RU2417082C2
(ru)
|
2009-07-14 |
2011-04-27 |
Учреждение Российской Академии Наук Институт Физиологически Активных Веществ Ран (Ифав Ран) |
Средство для восстановления утраченной памяти в норме и патологии у пациентов всех возрастных групп на основе n, n'-замещенных 3, 7-диазабицикло[3.3.1]нонанов, фармацевтическая композиция на его основе и способ ее применения
|
US9150813B2
(en)
|
2009-12-17 |
2015-10-06 |
The Lubrizol Corporation |
Lubricating composition containing an aromatic compound
|
RU2535664C2
(ru)
|
2010-01-27 |
2014-12-20 |
Аб Фарма Лтд |
Полигетероциклические соединения, используемые в качестве высокоэффективных ингибиторов вируса гепатита с
|
CN101851218B
(zh)
|
2010-04-27 |
2014-10-15 |
沈阳药科大学 |
4,5-二取代芳基异硒唑类衍生物及其用途
|
US20130338153A1
(en)
|
2010-06-10 |
2013-12-19 |
Afraxis, Inc. |
8-(2'-heterocycyl)pyrido[2.3-d]pyrimidin-7(8h)-ones for the treatment of cns disorders
|
DK2582674T3
(en)
|
2010-06-16 |
2014-12-15 |
Cymabay Therapeutics Inc |
GPR120 receptor agonists and uses thereof.
|
CA2806006A1
(fr)
|
2010-07-28 |
2012-02-02 |
Medizinische Universitaet Wien |
Derives de chalcone vinylogue et leur utilisation medicale
|
US9132136B2
(en)
|
2010-08-02 |
2015-09-15 |
Hoffmann-La Roche Inc. |
Pharmaceutical combination
|
JPWO2012036278A1
(ja)
|
2010-09-17 |
2014-02-03 |
大正製薬株式会社 |
グリシントランスポーター阻害物質
|
WO2012045196A1
(fr)
|
2010-10-09 |
2012-04-12 |
Abbott Laboratories |
Inhibiteurs de la phosphoglycérate kinase
|
US8802673B2
(en)
|
2011-03-24 |
2014-08-12 |
Hoffmann-La Roche Inc |
Heterocyclic amine derivatives
|
WO2013025484A1
(fr)
|
2011-08-12 |
2013-02-21 |
Lapchak Paul A |
Analogues de polyphénol pour traiter une ischémie
|
US8791108B2
(en)
|
2011-08-18 |
2014-07-29 |
Bristol-Myers Squibb Company |
Inhibitors of human immunodeficiency virus replication
|
EP2774917A4
(fr)
|
2011-11-04 |
2015-05-06 |
Ajinomoto Kk |
Composition pharmaceutique destinée au traitement du diabète
|
CA2862289C
(fr)
|
2012-02-10 |
2019-11-26 |
Constellation Pharmaceuticals, Inc. |
Modulateurs d'enzymes de modification par methylation, leurs compositions et utilisations
|
AU2013235038A1
(en)
|
2012-03-21 |
2014-10-09 |
Malvika Kaul |
Antimicrobial agents
|
RU2509770C2
(ru)
|
2012-06-22 |
2014-03-20 |
Общество с ограниченной ответственностью "Молекулярные Технологии" |
Новые химические соединения производные 2,4-диамино-1,3,5-триазина для профилактики и лечения заболеваний человека и животных
|
WO2014034898A1
(fr)
|
2012-08-30 |
2014-03-06 |
日本新薬株式会社 |
Dérivé de pyridine et médicament
|
EP2909214B1
(fr)
|
2012-10-22 |
2020-07-22 |
City of Hope |
Dérivés d'étoposide
|
AU2014243869A1
(en)
|
2013-03-13 |
2015-09-24 |
Boston Biomedical, Inc. |
3-(aryl or heteroaryl) methyleneindolin-2-one derivatives as inhibitors of cancer stem cell pathway kinases for the treatment of cancer
|
US20160108031A1
(en)
|
2013-04-30 |
2016-04-21 |
Heinrich-Heine-Universitat Dusseldorf |
Inhibitors of nhr2 and/or runx1/eto-tetramerization
|
KR20150027922A
(ko)
|
2013-09-04 |
2015-03-13 |
주식회사 대웅제약 |
신규한 항진균성 피리디닐하이드라자이드 유도체
|
US10011627B2
(en)
|
2013-09-09 |
2018-07-03 |
Youngene Therapeutics Co., Ltd |
C-aryl glucoside derivative, preparation methods thereof, and medical applications thereof
|
WO2015069110A1
(fr)
|
2013-11-07 |
2015-05-14 |
Aapa B.V. |
Multiples a(nta)gonistes de d2/antagonistes de h3 pour le traitement de troubles associés au snc
|
DK3121175T3
(da)
*
|
2014-03-17 |
2020-03-09 |
Daiichi Sankyo Co Ltd |
1,3-benzodioxolderivater som ezh1- og/eller ezh2-hæmmere
|
AU2015275826B2
(en)
|
2014-06-17 |
2019-05-16 |
Pfizer Inc. |
Substituted dihydroisoquinolinone compounds
|
CA2960757C
(fr)
|
2014-09-11 |
2022-09-06 |
Piramal Enterprises Limited |
Composes heterocycliques condenses a titre d'agonistes du gpr120
|
WO2016130396A1
(fr)
*
|
2015-02-13 |
2016-08-18 |
Constellation Pharmaceuticals, Inc. |
Modulateurs d'enzymes de modification méthylique, compositions et utilisations associées
|
BR112018001688B1
(pt)
|
2015-07-30 |
2023-05-02 |
Daiichi Sankyo Company, Limited |
Uso de um composto
|
US10759787B2
(en)
|
2015-11-19 |
2020-09-01 |
Jiangsu Hengrui Medicine Co., Ltd. |
Benzofuran derivative, preparation method thereof and use thereof in medicine
|
RS60315B1
(sr)
|
2016-01-13 |
2020-07-31 |
Gruenenthal Gmbh |
Derivati 3-((hetero-)aril)-alkil-8-amino-2-okso-1,3-diaza-spiro-[4.5]-dekana
|
MX2018009633A
(es)
|
2016-02-09 |
2018-12-17 |
Inventisbio Inc |
Inhibidor de indoleamina-2,3-dioxigenasa (ido).
|
US20170355708A1
(en)
*
|
2016-06-09 |
2017-12-14 |
Cadent Therapeutics, Inc. |
Potassium channel modulators
|
US20180016260A1
(en)
|
2016-07-14 |
2018-01-18 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
CN106727549A
(zh)
|
2016-11-26 |
2017-05-31 |
李�荣 |
一种治疗抑郁症的药物
|
KR20190105602A
(ko)
|
2017-01-19 |
2019-09-17 |
다이이찌 산쿄 가부시키가이샤 |
Htlv-1 관련 척수증을 치료하는 것에 사용하기 위한 의약 조성물
|
US11466020B2
(en)
|
2017-03-17 |
2022-10-11 |
Cornell University |
Compounds and compositions for inhibition and elimination of Zika infection and uses for same
|
BR112019024674A2
(pt)
|
2017-05-25 |
2020-06-16 |
Araxes Pharma Llc |
Inibidores covalentes da kras
|
EP3700527A4
(fr)
|
2017-10-25 |
2021-03-10 |
Children's Medical Center Corporation |
Inhibiteurs de papd5 et leurs méthodes d'utilisation
|
GB201718285D0
(en)
|
2017-11-03 |
2017-12-20 |
Discuva Ltd |
Antibacterial Compounds
|
JP2021035913A
(ja)
|
2017-12-21 |
2021-03-04 |
石原産業株式会社 |
N−メトキシアミド化合物又はその塩、及びそれらを含有する農園芸用殺菌剤
|
WO2019140322A1
(fr)
|
2018-01-12 |
2019-07-18 |
KDAc Therapeutics, Inc. |
Combinaison d'un inhibiteur sélectif de désacétylase d'histone 3 (hdac3) et d'un agent d'immunothérapie pour le traitement du cancer
|
JP2019168611A
(ja)
|
2018-03-23 |
2019-10-03 |
株式会社Adeka |
光学フィルタ
|
US20210093591A1
(en)
|
2018-03-30 |
2021-04-01 |
San Diego State University (SDSU) Foundation, dba San Diego State University Research Foundation |
Methods for mitigating and preventing proteostasis-based injuries
|
KR20210003160A
(ko)
|
2018-04-18 |
2021-01-11 |
콘스텔레이션 파마슈티칼스, 인크. |
메틸 변형 효소 조절제, 이의 조성물 및 용도
|